{"success":true,"type":"rich","version":"1.0","cache_age":86400,"width":440,"height":500,"provider_name":"RiffReporter","provider_url":"https:\/\/www.riffreporter.de","safety":"nonadult","asset_type":"article","url":"https:\/\/www.riffreporter.de\/de\/wissen\/spoligotyping","category":"Wissen","author_name":"Marcus Anh\u00e4user","author_url":"https:\/\/www.riffreporter.de\/de\/autorinnen-und-autoren\/marcus-anhaeuser","title":"#7 | CRISPR, Tuberkulose und die Suche des Jan van Embden","summary":"Als CRISPR noch keinen Namen hat und niemand wei\u00df, was das ist, nutzt ein niederl\u00e4ndisches Team die DNA-Sequenz erfolgreich im Kampf gegen Tuberkulose.","publication_date":"16.07.2019","thumbnail_url":"https:\/\/riff.media\/images\/embden-crispr-fachartikel.jpg?w=440&h=247&fit=crop-55-50&s=df864796010458fb02928ebe99e6bba4","thumbnail_width":440,"thumbnail_height":247,"thumbnail_credit":null,"thumbnail_credit_url":null,"thumbnail_credit_note":null,"html":"